JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Chk2 Inhibitor II (also known as BML-277) is an ATP-competitive inhibitor of Chk2 (checkpoint kinase 2) with an IC50 of 15 nM. It is 1000-fold more selective towards Chk2 than Chk1 and Cdk1/B kinases. BML-277 dose dependently protects human CD4+ and CD8+ T-cells from apoptosis due to ionizing radiation. It can efficiently rescue both T-cell populations from radiation-induced apoptosis in a dose-dependent manner with an observed EC50 of 3?7.6 uM. The concentration of BML-277 required for radioprotection is consistent with the biochemical measurement of chk2 inhibition.
References: J Med Chem. 2005 Mar 24; 48(6):1873-85; Nat Commun. 2011 Jul 19; 2:402.
Related CAS#:516480-80-1 (BML277 Acid, a metabolite of BML277)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!